Psykedeliske Stemmer Center for Psykedelisk Dannelse (Cepda)

In this episode you will meet Tehseen Noorani who is a Senior Lecturer in Clinical & Community Psychology and Anthropology at the University of East London. Noorani is furthermore a contributor to the psychedelic community in a wide variety of ways.

He was for example a co-investigator on the Johns Hopkins psilocybin for smoking-cessation study. He co-organized the free online psychedelic conference Psychedelic, Madness & Awakening which is still freely available. He has written defining papers detailing the processes of medicalizing psychedelic substances, and he is often cited for his original critical analyses. At present, Noorani is writing a monograph tracing the renewed scientific and therapeutic interest in psychedelic experiences in the global North, exploring implications for theories of psychopathology and approaches to mental health care. Weaving together scientific, medical, spiritual and aesthetic registers, this research is situated in the context of medicalisation and the ongoing ‘war on drugs’. The vantage point for this conversation is Noorani’s presentation at ICPR where he charted and envisioned methods for more rigorous psychedelic drug trial designs that better account for context.

We hope that you will enjoy the conversation!

Resources:


http://www.psychedelicsmadnessawakening.com/
https://twitter.com/tehseennoorani

Host: Kevin Mikkelsen

Production: Heine Volder

Music: Victor Lange

This podcast was made in a collaboration between Regnfang and Cepda - the Danish Center for Psychedelic Awareness.

The music in the podcast was made by Victor Lange.

Thank you to the Open Foundation for organizing and funding the ICPR conference and for providing us a quiet space during the conference for doing the podcast recordings.

Illustrations by Lizette Rosager

Follow the links to learn more about Cepda and Regnfang

In this podcast you will meet, Assistant Professor at Erasmus University, research associate at the University of California, and Editor-in-Chief of Journal Biosemiotics, Yogi Hendlin. Hendlin’s work draws on deep ecology, environmental philosophy, especially decolonial kinds, and public health policy. In focusing on the ecological aspects of psychedelics, Hendlin takes a less individualistic approach to the study of these substances than what is usually done in clinical research. And In this conversation, Hendlin unfolds what he terms the ‘ecodelic’ components of the psychedelic experience.
We hope you will enjoy the conversation!

Resources:


Read more about Hendlin’s work here

Host: Sidsel Marie

Production: Heine Volder

Music: Victor Lange

This podcast was made in a collaboration between Regnfang and Cepda - the Danish Center for Psychedelic Awareness.

The music in the podcast was made by Victor Lange.

Thank you to the Open Foundation for organizing and funding the ICPR conference and for providing us a quiet space during the conference for doing the podcast recordings.

Illustrations by Lizette Rosager

Follow the links to learn more about Cepda and Regnfang

In this podcast, you will meet PhD candidate in the history of science at the Université Picardie – Jules Vernes in France and associate researcher at the Paul Brousse hospital, Vincent Verroust. Verroust current PhD investigations focus on the discovery of psilocybin fungi in the west and are based on the archives of Prof. Roger Heim (1900 - 1979), which are kept at the French National Museum of Natural History, and contain a large volume of correspondence with the two psychedelic pioneers R. Gordon Wasson and Albert Hofmann. Apart from doing psychedelic research, Verroust is also founder and board member of the French Psychedelic Society. In the podcast Verroust provides a critical examination of the concept of ‘indigenous reciprocity’ as it is sometimes used within psychedelic research with regards to psilocybin.

We hope you will enjoy the conversation!

Resources:


Find out more about Verroust’s work here

Host: Sidsel Marie

Production: Heine Volder

Music: Victor Lange

This podcast was made in a collaboration between Regnfang and Cepda - the Danish Center for Psychedelic Awareness.

The music in the podcast was made by Victor Lange.

Thank you to the Open Foundation for organizing and funding the ICPR conference and for providing us a quiet space during the conference for doing the podcast recordings.

Illustrations by Lizette Rosager

Follow the links to learn more about Cepda and Regnfang

In this episode we talk to Kim Kuypers who is Associate Professor with Maastricht University, Faculty of Psychology and Neuroscience. She also obtained her Ph.D. there, in 2007.

For the following four years, she remained in Maastricht conducting postdoctoral research into the effects of MDMA on memory and driving performance. Additionally, in 2011, she was also a postdoctoral researcher at Belgium’s Ghent University where she studied the risk analysis of alcohol and drugs in traffic accidents. Her aim is to understand the neurobiology underlying flexible cognition, empathy, and well-being. Dr. Kuypers and her team employ a psychopharmacological model to study the acute and longer term effects of psychedelics on these behaviors and their underlying biology. Dr. Kuypers and the team at Maastricht have been investigating the optimal dose of microdosing LSD to improve mood, cognition and pain resilience, with minimal side effects and interferences to day to day life. In 2018, Dr. Kuypers was named the Principal Investigator for the Netherlands in the MAPS Phase 2 Clinical Trials of MDMA-Assisted Therapy for PTSD in Europe.

This episode was conducted on zoom a couple of weeks after the conference. We get to talk to professor Kuypers mainly about her studies on microdosing, potential side-effects of the practice, new trends and disputes in the field, and where the science of microdosing is headed next.

Host: Kevin Mikkelsen

Production: Heine Volder

Music: Victor Lange

This podcast was made in a collaboration between Regnfang and Cepda - the Danish Center for Psychedelic Awareness.

The music in the podcast was made by Victor Lange.

Thank you to the Open Foundation for organizing and funding the ICPR conference and for providing us a quiet space during the conference for doing the podcast recordings.

Illustrations by Lizette Rosager

Follow the links to learn more about Cepda and Regnfang

In this episode you will meet, medical doctor, psychiatrist, psychoanalyst, researcher, and teacher, Jeffrey Guss. Guss was Co-Principal Investigator and Director of Psychedelic Therapy Training for the NYU School of Medicine’s study on psilocybin-assisted psychotherapy in the treatment of cancer related existential distress. He is currently a Lead Trainer with Fluence, with a focus on the integration of psychedelic therapy with psychoanalysis. Furthermore, Guss is a study therapist in the NYU study on Psilocybin-Assisted treatment of Major Depressive Disorder, and he has published on the integration of ACT - Acceptance and Commitment Therapy - with psychedelic assisted therapy.  In this podcast, which was recorded through Zoom a few weeks after the conference, we talk with Guss about the broad therapeutic applications of psychedelic substances, and based on his research, Guss offers some insights into some of the psychological mechanisms that seem to impact this broad potential.
We hope you will enjoy the conversation!

Resources:


Find out more about Guss’ work and publications here
Open Source study on psilocybin-assisted psychotherapy in the treatment of cancer related existential distress:

https://pubmed-ncbi-nlm-nih-gov.ep.fjernadgang.kb.dk/27909164/

Host: Sidsel Marie

Production: Heine Volder

Music: Victor Lange

This podcast was made in a collaboration between Cepda - the Danish Center for Psychedelic Awareness and Regnfang.

The music in the podcast was made by Victor Lange.

Thank you to the Open Foundation for organizing and funding the ICPR conference and for providing us a quiet space during the conference for doing the podcast recordings.

Illustrations by Lizette Rosager

Follow the links to learn more about Cepda and Regnfang

In this podcast you will meet, Ph.D. and Chief Medical Officer at MAPS Public Benefit Corporation, Corine de Boer. The abbreviation ‘MAPS’ stands for the Multidisciplinary Association for Psychedelic Studies. MAPS has since its formation in 1986 been a prominent actor in the efforts of re-legitimizing the therapeutic use of psychedelic substances, especially with regards to MDMA-assisted therapy for people suffering from PTSD. MAPS has not only supported research and clinical efforts, but also made big contributions to the larger psychedelic ecosystem which includes being involved in public education, policy and harm reduction. In the US, MAPS has succeeded in getting MDMA-assisted therapy for PTSD all the way to phase 3 clinical trials, and if everything goes as planned, this will be a legal treatment option in the US within the next couple of years. It is expected that Europe will follow that development soon after. In this podcast, we talk with de Boer about the potential of MDMA-assisted therapy more generally and about the current status of research in MDMA-assisted therapy in Europe more specifically.

We hope you will enjoy the conversation!

Host: Kevin Mikkelsen

Production: Heine Volder

Music: Victor Lange

This podcast was made in a collaboration between Cepda - the Danish Center for Psychedelic Awareness and Regnfang. 

The music in the podcast was made by Victor Lange.

Thank you to the Open Foundation for organizing and funding the ICPR conference and for providing us a quiet space during the conference for doing the podcast recordings.

Illustrations by Lizette Rosager

Follow the links to learn more about Cepda and Regnfang